The role of angiotensin II in cardiovascular disease-induced cancer growth

Cardiooncology. 2026 May 1. doi: 10.1186/s40959-026-00495-x. Online ahead of print.ABSTRACTBACKGROUND: The higher incidence of cancer in patients with cardiovascular disease (CVD) has historically been explained by shared risk factors. Recent studies suggest, however, a causal relationship. Neverthe

B Benji van Berlo

ERG is a regulator of dynamic and reversible endothelial plasticity

Genome Med. 2026 May 1;18(1):53. doi: 10.1186/s13073-026-01638-6.ABSTRACTBACKGROUND: Endothelial cells (ECs) orchestrate vascular homeostasis and resilience but can undergo reprogramming into a mesenchymal-like phenotype through an endothelial-to-mesenchymal transition (EndMT). Crucially, EndMT is a

K Kristen Schulz

Therapeutic Approach to Heart Failure Management: Insight from Clinical Trials

South Med J. 2026 May 4;119(5):252-258. doi: 10.14423/SMJ.0000000000001965.ABSTRACTHeart failure (HF) is a global burden and, irrespective of age, sex, race, nationality, and geography, affects individuals across the world. Several reports mentioned that, globally, more than 64 million people, which

A Ambrish Kumar

Recognition and Management of Pregnancy-Associated Venous Thromboembolism

J Emerg Nurs. 2026 May;52(3):583-592. doi: 10.1016/j.jen.2025.10.022.ABSTRACTPregnancy-associated venous thromboembolism is a leading cause of maternal mortality, particularly in the postpartum period. Thrombotic risk is heightened by physiological adaptations of pregnancy, including hypercoagulabil

J John Ramos